- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular Mechanisms of Bortezomib Resistant Adenocarcinoma Cells
Authors
Keywords
-
Journal
PLoS One
Volume 6, Issue 12, Pages e27996
Publisher
Public Library of Science (PLoS)
Online
2011-12-23
DOI
10.1371/journal.pone.0027996
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo
- (2010) G. Dasmahapatra et al. BLOOD
- Building on bortezomib: second-generation proteasome inhibitors as anti-cancer therapy
- (2010) Lawrence R. Dick et al. DRUG DISCOVERY TODAY
- Bortezomib-resistant myeloma cell lines: a role for mutated PSMB5 in preventing the accumulation of unfolded proteins and fatal ER stress
- (2010) M Ri et al. LEUKEMIA
- The proteasome load versus capacity balance determines apoptotic sensitivity of multiple myeloma cells to proteasome inhibition
- (2009) G. Bianchi et al. BLOOD
- Carfilzomib can induce tumor cell death through selective inhibition of the chymotrypsin-like activity of the proteasome
- (2009) F. Parlati et al. BLOOD
- Different mutants of PSMB5 confer varying bortezomib resistance in T lymphoblastic lymphoma/leukemia cells derived from the Jurkat cell line
- (2009) Shuqing Lü et al. EXPERIMENTAL HEMATOLOGY
- Characterization of the ubiquitin–proteasome system in bortezomib-adapted cells
- (2009) T Rückrich et al. LEUKEMIA
- Proteasome inhibitors in the treatment of multiple myeloma
- (2009) J J Shah et al. LEUKEMIA
- Molecular mechanisms of proteasome assembly
- (2009) Shigeo Murata et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Many facets of bortezomib resistance/susceptibility
- (2008) S. Kumar et al. BLOOD
- Molecular basis of bortezomib resistance: proteasome subunit 5 (PSMB5) gene mutation and overexpression of PSMB5 protein
- (2008) R. Oerlemans et al. BLOOD
- Sensitivity of tumor cells to proteasome inhibitors is associated with expression levels and composition of proteasome subunits
- (2008) Antonia Busse et al. CANCER
- Proteasome Subunit Pharmacogenomics: Gene Resequencing and Functional Genomics
- (2008) L. Wang et al. CLINICAL CANCER RESEARCH
- Mechanisms of proteasome inhibitor action and resistance in cancer
- (2008) David J. McConkey et al. DRUG RESISTANCE UPDATES
- Overexpression of the PSMB5 gene contributes to bortezomib resistance in T-lymphoblastic lymphoma/leukemia cells derived from Jurkat line
- (2008) Shuqing Lü et al. EXPERIMENTAL HEMATOLOGY
- Point Mutation of the Proteasome 5 Subunit Gene Is an Important Mechanism of Bortezomib Resistance in Bortezomib-Selected Variants of Jurkat T Cell Lymphoblastic Lymphoma/Leukemia Line
- (2008) S. Lu et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Turnover of the Human Proteome: Determination of Protein Intracellular Stability by Dynamic SILAC
- (2008) Mary K. Doherty et al. JOURNAL OF PROTEOME RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started